Sodium hydride → Methyl 2-(4-(bis(4-chlorophenyl)methyl)-2-oxopiperazin-1-yl)acetate

HRID 1027467Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1027467
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([CH:8]([C:16]2[CH:21]=[CH:20][C:19]([Cl:22])=[CH:18][CH:17]=2)[N:9]2[CH2:14][CH2:13][NH:12][C:11](=[O:15])[CH2:10]2)=[CH:4][CH:3]=1.Br[CH2:24][C:25]([O:27][CH3:28])=[O:26].[H-].[Na+]>C1COCC1>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH:8]([C:16]2[CH:21]=[CH:20][C:19]([Cl:22])=[CH:18][CH:17]=2)[N:9]2[CH2:14][CH2:13][N:12]([CH2:24][C:25]([O:27][CH3:28])=[O:26])[C:11](=[O:15])[CH2:10]2)=[CH:6][CH:7]=1

Komponenten

5

Edukt 3

HCID 24758Sodium hydrideHCID 60984Methyl bromoacetateHCID 689317794-(Bis(4-chlorophenyl)methyl)piperazin-2-one

Produkt 1

HCID 68928666Methyl 2-(4-(bis(4-chlorophenyl)methyl)-2-oxopiperazin-1-yl)acetateAusbeute 73,2 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

To a solution of 4-(bis(4-chlorophenyl)methyl)piperazin-2-one (180 mg, 537 μmol) in 10 mL of dry THF was added methyl 2-bromoacetate (60 μl, 644 μmol), followed by sodium hydride, 60% dispersion in mineral oil (16 μl, 644 μmol). After stirring rt overnight, the solvent was evaporated to dryness and was directly submitted to column chromatography (SiO2, hexane to hexane/EtOAc=100:5 to 100:10 to 100:20 to 100:30) to give methyl 2-(4-(bis(4-chlorophenyl)methyl)-2-oxopiperazin-1-yl)acetate (160 mg) as a white solid.

Aufarbeitung

  1. customthe solvent was evaporated to dryness

Quellen und Nachweise

ORD-Eintrag
ord-7cdac3b39e7d4555987a4265208ab217
Quelldatensatz
uspto-grants-2014_05
Patentnummer
US08735383B2

Notizen zur Reaktion

Wird geladen…